Androgen metabolism in prostate cancer: from molecular mechanisms to clinical consequences.

Chang, K-H; Ercole, C E; Sharifi, N

Chang, K-H; Ercole, C E; Sharifi, N.

Affiliation

Chang KH; Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.
Ercole CE; Department of Urology, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA.
Sharifi N; 1] Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA [2] Department of Urology, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA [3] Department of Solid Tumor Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.

Br J Cancer ; 111(7): 1249-54, 2014 Sep 23.

Article in En | MEDLINE | ID: mdl-24867689

Subject(s)

Androgens/biosynthesis; Prostatic Neoplasms, Castration-Resistant/metabolism; Animals; Dihydrotestosterone/metabolism; Drug Resistance, Neoplasm; Humans; Hydroxysteroid Dehydrogenases/genetics; Hydroxysteroid Dehydrogenases/physiology; Male; Molecular Targeted Therapy; Prostatic Neoplasms, Castration-Resistant/drug therapy; Testosterone/metabolism

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms, Castration-Resistant / Androgens Type of study: Prognostic_studies Limits: Animals / Humans / Male Language: En Journal: Br J Cancer Year: 2014 Document type: Article

Fulltext

XML

PubMed Links

Search on Google